Lexicon Pharmaceuticals, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for LXRX, updated each market day.
LXRX AI Sentiment
AI sees no strong directional signal for Lexicon Pharmaceuticals, Inc. stock over the next 10 market days.
Prediction date: Sept. 23, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Sector
Exchange
Market Cap
$905,485,325
Cap Tier
Employees
81
Headquarters
THE WOODLANDS, TX
Listed Since
April 7, 2000
Website
LXRX Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LXRX Volatility
Lexicon Pharmaceuticals, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
